Cell and molecular biology of intervertebral disc degeneration: Current understanding and implications for potential therapeutic strategies

Cell Proliferation

Volumn 47, Issue 5, 2014, Pages 381-390

  Wang, S ^a   Rui, Y ^a   Lu, J ^a   Wang, C ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; COLLAGEN TYPE 2; GROWTH DIFFERENTIATION FACTOR 5; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; OSTEOGENIC PROTEIN 1; STROMELYSIN; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA; VERSICAN; PROTEOGLYCAN;

ARTICLE; CELL COUNT; CELL METABOLISM; CELL POPULATION; CELL TRANSPLANTATION; CELL VIABILITY; COLLAGEN SYNTHESIS; CYTOLOGY; EXTRACELLULAR MATRIX; GENE THERAPY; HOMEOSTASIS; HUMAN; HYDROSTATIC PRESSURE; INTERVERTEBRAL DISK DEGENERATION; LOW BACK PAIN; MOLECULAR BIOLOGY; NONHUMAN; SPINE MOBILITY; AGING; ANIMAL; BIOLOGICAL THERAPY; DISEASE MODEL; INTERVERTEBRAL DISC DEGENERATION; INTERVERTEBRAL DISK; METABOLISM; MOUSE; PATHOLOGY; RABBIT; RAT; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

AGING; ANIMALS; CELL- AND TISSUE-BASED THERAPY; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; GENETIC THERAPY; HUMANS; INTERVERTEBRAL DISC; INTERVERTEBRAL DISC DEGENERATION; LOW BACK PAIN; MICE; PROTEOGLYCANS; RABBITS; RATS; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING;

EID: 84908596600     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12121     Document Type: Article

References (111)

1. Freemont AJ (2009) The cellular pathobiology of the degenerate intervertebral disc and discogenic back pain. Rheumatology (Oxford) 48, 5-10.
2. Singh K, Masuda K, An HS (2005) Animal models for human disc degeneration. Spine J. 5(6 Suppl), 267S-279S.
3. Smith LJ, Nerurkar NL, Choi KS, Harfe BD, Elliott DM (2011) Degeneration and regeneration of the intervertebral disc: lessons from development. Dis. Model Mech. 4, 31-41.
4. Schoenfeld AJ, Nelson JH, Burks R, Belmont PJ Jr (2011) Incidence and risk factors for lumbar degenerative disc disease in the United States military 1999-2008. Mil. Med. 176, 1320-1324.
5. Kales SN, Linos A, Chatzis C, Sai Y, Halla M, Nasioulas G et al. (2004) The role of collagen IX tryptophan polymorphisms in symptomatic intervertebral disc disease in Southern European patients. Spine (Phila Pa 1976) 29, 1266-1270.
6. McBeth J, Jones K (2007) Epidemiology of chronic musculoskeletal pain. Best Pract. Res. Clin. Rheumatol. 21, 403-425.
7. Dagenais S, Caro J, Haldeman S (2008) A systematic review of low back pain cost of illness studies in the United States and internationally. Spine J. 8, 8-20.
8. Kuslich SD, Ulstrom CL, Michael CJ (1991) The tissue origin of low back pain and sciatica: a report of pain response to tissue stimulation during operations on the lumbar spine using local anesthesia. Orthop. Clin. North Am. 22, 181-187.
9. Luoma K, Riihimäki H, Luukkonen R, Raininko R, Viikari-Juntura E, Lamminen A (2000) Low back pain in relation to lumbar disc degeneration. Spine (Phila Pa 1976) 25, 487-492.
10. Adams MA, Roughley PJ (2006) What is intervertebral disc degeneration, and what causes it? Spine (Phila Pa 1976) 31, 2151-2161.
11. Boxberger JI, Sen S, Yerramalli CS, Elliott DM (2006) Nucleus pulposus glycosaminoglycan content is correlated with axial mechanics in rat lumbar motion segments. J. Orthop. Res. 24, 1906-1915.
12. Costi JJ, Stokes IA, Gardner-Morse MG, Iatridis JC (2008) Frequency-dependent behavior of the intervertebral disc in response to each of six degree of freedom dynamic loading: solid phase and fluid phase contributions. Spine 33, 1731-1738.
13. Hadjipavlou AG, Tzermiadianos MN, Bogduk N, Zindrick MR (2008) The pathophysiology of disc degeneration: a critical review. J. Bone Joint Surg. Br. 90, 1261-1270.
14. Le Maitre CL, Freemont AJ, Hoyland JA (2004) Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J. Pathol. 204, 47-54.
15. Freemont AJ, Byers RJ, Taiwo YO, Hoyland JA (1999) In situ zymographic localisation of type II collagen degrading activity in osteoarthritic human articular cartilage. Ann. Rheum. Dis. 58, 357-365.
16. Mee AP, Hoyland JA, Braidman IP, Freemont AJ, Davies M, Mawer EB (1996) Demonstration of vitamin D receptor transcripts in actively resorbing osteoclasts in bone sections. Bone 18, 295-299.
17. Braidman I, Baris C, Wood L, Selby P, Adams J, Freemont A et al. (2000) Preliminary evidence for impaired estrogen receptor-alpha protein expression in osteoblasts and osteocytes from men with idiopathic osteoporosis. Bone 26, 423-427.
18. Mirza SK, Deyo RA (2007) Systematic review of randomized trials comparing lumbar fusion surgery to nonoperative care for treatment of chronic back pain. Spine 32, 816-823.
19. Hanley EN Jr, Herkowitz HN, Kirkpatrick JS, Wang JC, Chen MN, Kang JD (2010) Debating the value of spine surgery. J. Bone Joint Surg. Am. 92, 1293-1304.
20. Humzah MD, Soames RW (1988) Human intervertebral disc: structure and function. Anat. Rec. 220, 337-356.
21. Eyre DR, Muir H (1976) Types I and II collagens in interver-tebral disc. Interchanging radial distributions in annulus fibrosus. Biochem. J. 157, 267-270.
22. Cassidy JJ, Hiltner A, Baer E (1989) Hierarchical structure of the intervertebral disc. Connect. Tissue Res. 23, 75-88.
23. Roughley PJ (2006) The structure and function of cartilage proteoglycans. Eur. Cell Mater. 12, 92-101.
24. Melrose J, Ghosh P, Taylor TK (2001) A comparative analysis of the differential spatial and temporal distributions of the large (aggrecan, versican) and small (decorin, biglycan, fibromodulin) proteoglycans of the intervertebral disc. J. Anat. 198, 3-15.
25. Melrose J, Smith S, Ghosh P (2000) Differential expression of proteoglycan epitopes by ovine intervertebral disc cells. J. Anat. 197, 189-198.
26. Melrose J, Smith SM, Appleyard RC, Little CB (2007) Aggrecan, versican and type VI collagen are components of annular translamellar crossbridges in the intervertebral disc. Eur. Spine J. 17, 314-324.
27. Urban JP, Smith S, Fairbank JC (2004) Nutrition of the intervertebral disc. Spine (Phila Pa 1976) 29, 2700-2709.
28. Heuer F, Schmidt H, Wilke HJ (2008) Stepwise reduction of functional spinal structures increase disc bulge and surface strains. J. Biomech. 41, 1953-1960.
29. O'Connell GD, Johannessen W, Vresilovic EJ, Elliott DM (2007) Human internal disc strains in axial compression measured noninvasively using magnetic resonance imaging. Spine (Phila Pa 1976) 32, 2860-2868.
30. Roughley PJ, Melching LI, Heathfield TF, Pearce RH, Mort JS (2006) The structure and degradation of aggrecan in human intervertebral disc. Eur. Spine J. 15(Suppl 3), S326-S332.
31. Walmsley R (1953) The development and growth of the intervertebral disc. Edinb. Med. J. 60, 341-364.
32. Hunter CJ, Matyas JR, Duncan NA (2003) The notochordal cell in the nucleus pulposus: a review in the context of tissue engineering. Tissue Eng. 9, 667-677.
33. Maldonado BA, Oegema TR Jr (1992) Initial characterization of the metabolism of intervertebral disc cells encapsulated in microspheres. J. Orthop. Res. 10, 677-690.
34. Weiler C, Nerlich AG, Schaaf R, Bachmeier BE, Wuertz K, Boos N (2010) Immunohistochemical identification of notochordal markers in cells in the aging human lumbar intervertebral disc. Eur. Spine J. 19, 1761-1770.
35. Choi KS, Cohn MJ, Harfe BD (2008) Identification of nucleus pulposus precursor cells and notochordal remnants in the mouse: implications for disk degeneration and chordoma formation. Dev. Dyn. 237, 3953-3958.
36. Feng G, Yang X, Shang H, Marks IW, Shen FH, Katz A et al. (2010) Multipotential differentiation of human anulus fibrosus cells: an in vitro study. J. Bone Joint Surg. Am. 92, 675-685.
37. Henriksson H, Thornemo M, Karlsson C, Hägg O, Junevik K, Lindahl A et al. (2009) Identification of cell proliferation zones, progenitor cells and a potential stem cell niche in the intervertebral disc region: a study in four species. Spine (Phila Pa 1976) 34, 2278-2287.
38. Sakai D, Nakamura Y, Nakai T, Mishima T, Kato S, Grad S et al. (2012) Exhaustion of nucleus pulposus progenitor cells with ageing and degeneration of the intervertebral disc. Nat. Commun. 3, 1264.
39. Skaggs DL, Weidenbaum M, Iatridis JC, Ratcliffe A, Mow VC (1994) Regional variation in tensile properties and biochemical composition of the human lumbar anulus fibrosus. Spine (Phila Pa 1976) 19, 1310-1319.
40. Ahsan R, Tajima N, Chosa E, Sugamata M, Sumida M, Hamada M (2001) Biochemical and morphological changes in herniated human intervertebral disc. J. Orthop. Sci. 6, 510-518.
41. Adams MA, Roughley PJ (2006) What is intervertebral disc degeneration, and what causes it? Spine (Phila Pa 1976) 31, 2151-2161.
42. Setton LA, Chen J (2006) Mechanobiology of the intervertebral disc and relevance to disc degeneration. J. Bone Joint Surg. Am. 88(Suppl 2), 52-57.
43. Konttinen YT, Kemppinen P, Li TF, Waris E, Pihlajamäki H, Sorsa T et al. (1999) Transforming and epidermal growth factors in degenerated intervertebral discs. J. Bone Joint Surg. Br. 81, 1058-1063.
44. Jin H, Shen J, Wang B, Wang M, Shu B, Chen D (2011) TGF-β signaling plays an essential role in the growth and maintenance of intervertebral disc tissue. FEBS Lett. 585, 1209-1215.
45. Wang H, Kroeber M, Hanke M, Ries R, Schmid C, Poller W et al. (2003) Release of active and depot GDF-5 after adenovirus-mediated overexpression stimulates rabbit and human intervertebral disc cells. J. Mol. Med. (Berlin) 82, 126-134.
46. Le Maitre CL, Richardson SM, Baird P, Freemont AJ, Hoyland JA (2005) Expression of receptors for putative anabolic growth factors in human intervertebral disc: implications for repair and regeneration of the disc. J. Pathol. 207, 445-452.
47. Wang H, Kroeber M, Hanke M, Ries R, Schmid C, Poller W et al. (2004) Release of active and depot GDF-5 after adenovirus-overexpression stimulates rabbits and human intervertebral disc cells. J. Mol. Med. (Berlin) 82, 126-134.
48. Fujita N, Imai J, Suzuki T, Yamada M, Ninomiya K, Miyamoto K et al. (2008) Vascular endothelial growth factor-A is a survival factor for nucleus pulposus cells in the intervertebral disc. Biochem. Biophys. Res. Commun. 372, 367-372.
49. Paul R, Haydon RC, Cheng H, Ishikawa A, Nenadovich N, Jiang W et al. (2003) Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine (Phila Pa 1976) 28, 755-763.
50. Wallach CJ, Gilbertson LG, Kang JD (2003) Gene therapy applications for intervertebral disc degeneration. Spine (Phila Pa 1976) 28(15 Suppl):S93-S98.
51. Kim KW, Kim YS, Ha KY, Woo YK, Park JB, Park WS et al. (2005) An autocrine or paracrine Fas-mediated counterattack: a potential mechanism for apoptosis of notochordal cells in intact rat nucleus pulposus. Spine (Phila Pa 1976) 30, 1247-1251.
52. Heyde CE, Tschoeke SK, Hellmuth M, Hostmann A, Ertel W, Oberholzer A (2006) Trauma induces apoptosis in human thoracolumbar intervertebral discs. BMC Clin. Pathol. 23, 5.
53. Wallach CJ, Sobajima S, Watanabe Y, Kim JS, Georgescu HI, Robbins P et al. (2003) Gene transfer of the catabolic inhibitor TIMP-1 increases measured proteoglycans in cells from degenerated human intervertebral discs. Spine (Phila Pa 1976) 28:2331-2337.
54. Le Maitre CL, Freemont AJ, Hoyland JA (2004) Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J. Pathol. 204, 47-54.
55. Nishida T (1999) Kinetics of tissue and serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 in intervertebral disc degeneration and disc herniation. Kurume Med. J. 46, 39-50.
56. Patel KP, Sandy JD, Akeda K, Miyamoto K, Chujo T, An HS et al. (2007) Aggrecanases and aggrecanase-generated fragments in the human intervertebral disc at early and advanced stages of disc degeneration. Spine (Phila Pa 1976) 32, 2596-2603.
57. Battie MC, Videman T (2006) Lumbar disc degeneration: epidemiology and genetics. J. Bone Joint Surg. Am. 88(Suppl 2), 3-9.
58. Battie MC, Videman T, Kaprio J, Gibbons LE, Gill K, Manninen H et al. (2009) The Twin Spine Study: contributions to a changing view of disc degeneration. Spine J. 9, 47-59.
59. Battie MC, Videman T, Levalahti E, Gill K, Kaprio J (2007) Heritability of low back pain and the role of disc degeneration. Pain 131, 272-280.
60. Kelempisioti A, Eskola PJ, Okuloff A, Karjalainen U, Takatalo J, Daavittila I et al. (2011) Genetic susceptibility of intervertebral disc degeneration among young Finnish adults. BMC Med. Genet. 12, 153.
61. Seki S, Kawaguchi Y, Chiba K, Mikami Y, Kizawa H, Oya T et al. (2005) A functional SNP in CILP, encoding cartilage intermediate layer protein, is associated with susceptibility to lumbar disc disease. Nat. Genet. 37, 607-612.
62. Karasugi T, Semba K, Hirose Y, Kelempisioti A, Nakajima M, Miyake A et al. (2009) Association of the tag SNPs in the human SKT gene (KIAA1217) with lumbar disc herniation. J. Bone Miner. Res. 24, 1537-1543.
63. Seki S, Tsumaki N, Motomura H, Nogami M, Kawaguchi Y, Hori T et al. (2014) Cartilage intermediate layer protein promotes lumbar disc degeneration. Biophys. Res. Commun. pii: S0006-291X(14)00457-4.
64. Boos N, Weissbach S, Rohrbach H, Weiler C, Spratt KF, Nerlich AG (2002) Classification of age-related changes in lumbar intervertebral discs: 2002 Volvo Award in basic science. Spine (Phila Pa 1976) 27, 2631-2644.
65. Nomura T, Mochida J, Okuma M, Nishimura K, Sakabe K (2001) Nucleus pulposus allograft retards intervertebral disc degeneration. Clin. Orthop. Relat. Res. 389, 94-101.
66. Gruber HE, Hanley EN Jr. Analysis of aging and degeneration of the human intervertebral disc (1998) Comparison of surgical specimens with normal controls. Spine (Phila Pa 1976) 23, 751-757.
67. Hastreiter D, Ozuna RM, Spector M (2001) Regional variations in certain cellular characteristics in human lumbar intervertebral discs, including the presence of alpha-smooth muscle actin. J. Orthop. Res. 19, 597-604.
68. Ishii T, Tsuji H, Sano A, Katoh Y, Matsui H, Terahata N (1991) Histochemical and ultrastructural observations on brown degeneration of human intervertebral disc. J. Orthop. Res. 9, 78-90.
69. Bibby SR, Fairbank JC, Urban MR, Urban JP (2002) Cell viability in scoliotic discs in relation to disc deformity and nutrient levels. Spine (Phila Pa 1976) 27, 2220-2228; discussion 2227-2228.
70. Le Maitre CL, Freemont AJ, Hoyland JA (2007) Accelerated cellular senescence in degenerate intervertebral discs: a possible role in the pathogenesis of intervertebral disc degeneration. Arthritis Res. Ther. 9, R45.
71. Tolonen J, Grönblad M, Vanharanta H, Virri J, Guyer RD, Rytömaa T et al. (2006) Growth factor expression in degenerated intervertebral disc tissue. An immunohistochemical analysis of transforming growth factor beta, fibroblast growth factor and platelet-derived growth factor. Eur. Spine J. 15, 588-596.
72. Johnson WE, Roberts S (2003) Human intervertebral disc cell morphology and cytoskeletal composition: a preliminary study of regional variations in health and disease. J. Anat. 203, 605-612.
73. Oegema TR Jr (2002) The role of disc cell heterogeneity in determining disc biochemistry: a speculation. Biochem. Soc. Trans. 30, 839-844.
74. Kim KW, Kim YS, Ha KY, Woo YK, Park JB, Park WS et al. (2005) An autocrine or paracrine Fas-mediated counterattack: a potential mechanism for apoptosis of notochordal cells in intact rat nucleus pulposus. Spine (Phila Pa 1976) 30, 1247-1251.
75. Sztrolovics R, Grover J, Cs-Szabo G, Shi SL, Zhang Y, Mort JS et al. (2002) The characterization of versican and its message in human articular cartilage and intervertebral disc. J. Orthop. Res. 20, 257-266.
76. Walsh AJ, Bradford DS, Lotz JC (2004) In vivo growth factor treatment of degenerated intervertebral discs. Spine (Phila Pa 1976) 29, 156-163.
77. Chujo T, An HS, Akeda K, Miyamoto K, Muehleman C, Attawia M et al. (2006) Effects of growth differentiation factor-5 on the intervertebral disc - in vitro bovine study and in vivo rabbit disc degeneration model study. Spine (Phila Pa 1976) 31, 2909-2917.
78. Kawakami M, Matsumoto T, Hashizume H, Kuribayashi K, Chubinskaya S, Yoshida M (2005) Osteogenic protein-1 (osteogenic protein-1/bone morphogenetic protein-7) inhibits degeneration and pain-related behavior induced by chronically compressed nucleus pulposus in the rat. Spine (Phila Pa 1976) 30, 1933-1939.
79. An HS, Takegami K, Kamada H, Nguyen CM, Thonar EJ, Singh K et al. (2005) Intradiscal administration of osteogenic protein-1 increases intervertebral disc height and proteoglycan content in the nucleus pulposus in normal adolescent rabbits. Spine (Phila Pa 1976) 30, 25-31.
80. Masuda K, Imai Y, Okuma M, Muehleman C, Nakagawa K, Akeda K et al. (2006) Osteogenic protein-1 injection into a degenerated disc induces the restoration of disc height and structural changes in the rabbit anular puncture model. Spine (Phila Pa 1976) 31, 742-754.
81. Miyamoto K, Masuda K, Kim JG, Inoue N, Akeda K, Andersson GB et al. (2006) Intradiscal injections of osteogenic protein-1 restore the viscoelastic properties of degenerated intervertebral discs. Spine J. 6, 692-703.
82. Imai Y, Okuma M, An HS, Nakagawa K, Yamada M, Muehleman C et al. (2007) Restoration of disc height loss by recombinant human osteogenic protein-1 injection into intervertebral discs undergoing degeneration induced by an intradiscal injection of chondroitinase ABC. Spine (Phila Pa 1976) 32, 1197-1205.
83. Krüger JP, Freymannx U, Vetterlein S, Neumann K, Endres M, Kaps C (2013) Bioactive factors in platelet-rich plasma obtained by apheresis. Transfus. Med. Hemother. 40, 432-440.
84. Nagae M, Ikeda T, Mikami Y, Hase H, Ozawa H, Matsuda K et al. (2007) Intervertebral disc regeneration using platelet-rich plasma and biodegradable gelatin hydrogel microspheres. Tissue Eng. 13, 147-158.
85. Sawamura K, Ikeda T, Nagae M, Okamoto S, Mikami Y, Hase H et al. (2009) Characterization of in vivo effects of platelet-rich plasma and biodegradable gelatin hydrogel microspheres on degenerated intervertebral discs. Tissue Eng. 15, 3719-3727.
86. Gullung GB, Woodall JW, Tucci MA, James J, Black DA, McGuire RA (2011) Platelet-rich plasma effects on degenerative disc disease: analysis of histology and imaging in an animal model. Evid. Based Spine Care J. 2, 13-18.
87. Obata S, Akeda K, Imanishi T, Masuda K, Bae W, Morimoto R et al. (2012) Effect of autologous platelet-rich plasma-releasate on intervertebral disc degeneration in the rabbit anular puncture model: a preclinical study. Arthritis Res. Ther. 14, R241.
88. Hu X, Wang C, Rui Y (2012) [An experimental study on effect of autologous platelet-rich plasma on treatment of early intervertebral disc degeneration.] Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 26, 977-983 (in Chinese).
89. Seki S, Asanuma-Abe Y, Masuda K, Kawaguchi Y, Asanuma K, Muehleman C, Iwai A et al. (2009) Effect of small interference RNA (siRNA) for ADAMTS5 on intervertebral disc degeneration in the rabbit anular needle-puncture model. Arthritis Res Ther 11(6), R166.
90. Sai JM, Hu YG, Wang DC (2007) Constructing adeno-associated virus-TGFbeta3 and comparing its biological effect on proteoglycan synthesis in dedifferentiated nucleus pulpous cells with adenovirus-TGFbeta1. Chin. Med. Sci. J. 22, 113-118.
91. Zhang YH, Zhao CQ, Jiang LS, Dai LY (2011) Lentiviral shRNA silencing of CHOP inhibits apoptosisinduced by cyclic stretch in rat annular cells and attenuates disc degeneration in the rats. Apoptosis 16, 594-605.
92. Moon SH, Nishida K, Gilbertson LG, Lee HM, Kim H, Hall RA et al. (2008) Biologic response of human intervertebral disc cells to gene therapy cocktail. Spine (Phila Pa 1976) 33, 1850-1855.
93. Leo BM, Li X, Balian G, Anderson DG (2004) In vivo bioluminescent imaging of virus-mediated gene transfer and transduced cell transplantation in the intervertebral disc. Spine (Phila Pa 1976) 29, 838-844.
94. Park JB, Chang H, Kim KW (2001) Expression of Fas ligand and apoptosis of disc cells in herniated lumbar disc tissue. Spine (Phila Pa 1976) 26, 618-621.
95. Takada T, Nishida K, Doita M, Kurosaka M (2002) Fas ligand exists on intervertebral disc cells: a potential molecular mechanism for immune privilege of the disc. Spine (Phila Pa 1976) 27, 1526-1530.
96. Ganey T, Libera J, Moos V, Alasevic O, Fritsch KG, Meisel HJ et al. (2003) Disc chondrocyte transplantation in a canine model: a treatment for degenerated or damaged intervertebral disc. Spine (Phila Pa 1976) 28, 2609-2620.
97. Gruber HE, Johnson TL, Leslie K, Ingram JA, Martin D, Hoelscher G et al. (2002) Autologous intervertebral disc cell implantation: a model using Psammomys obesus, the sand rat. Spine (Phila Pa 1976) 27, 1626-1633.
98. Sakai D, Mochida J, Iwashina T, Watanabe T, Nakai T, Ando K et al. (2005) Differentiation of mesenchymal stem cells transplanted to a rabbit degenerative disc model: potential and limitations for stem cell therapy in disc regeneration. Spine (Phila Pa 1976) 30, 2379-2387.
99. Zhang YG, Guo X, Xu P, Kang LL, Li J (2005) Bone mesenchymal stem cells transplanted into rabbit intervertebral discs can increase proteoglycans. Clin. Orthop. Relat. Res. 430, 219-226.
100. Sobajima S, Vadala G, Shimer A, Kim JS, Gilbertson LG, Kang JD (2008) Feasibility of a stem cell therapy for intervertebral disc degeneration. Spine J. 8, 888-896.
101. Strassburg S, Richardson SM, Freemont AJ, Hoyland JA (2010) Co-culture induces mesenchymal stem cell differentiation and modulation of the degenerate human nucleus pulposus cell phenotype. Regen. Med. 5, 701-711.
102. Kim DH, Kim SH, Heo SJ, Shin JW, Lee SW, Park SA (2009) Enhanced differentiation of mesenchymal stem cells into NP-like cells via 3D co-culturing with mechanical stimulation. J. Biosci. Bioeng. 108, 63-67.
103. Erwin WM, Inman RD (2006) Notochord cells regulate intervertebral disc chondrocyte proteoglycan production and cell proliferation. Spine (Phila Pa 1976) 31, 1094-1099.
104. Erwin WM, Ashman K, O'Donnel P, Inman RD (2006) Nucleus pulposus notochord cells secrete connective tissue growth factor and up-regulate proteoglycan expression by intervertebral disc chondrocytes. Arthritis Rheum. 54, 3859-3867.
105. Cappello R, Bird JL, Pfeiffer D, Bayliss MT, Dudhia J (2006) Notochordal cell produce and assemble extracellular matrix in a distinct manner, which may be responsible for the maintenance of healthy nucleus pulposus. Spine (Phila Pa 1976) 31, 873-882; discussion 883.
106. Korecki CL, Taboas JM, Tuan RS, Iatridis JC (2010) Notochordal cell conditioned medium stimulates mesenchymal stem cell differentiation toward a young nucleus pulposus phenotype. Stem Cell Res. Ther. 1, 18.
107. Risbud MV, Guttapalli A, Tsai TT, Lee JY, Danielson KG, Vaccaro AR et al. (2007) Evidence for skeletal progenitor cells in the degenerate human intervertebral disc. Spine (Phila Pa 1976) 32, 2537-2544.
108. Blanco JF, Graciani IF, Sanchez-Guijo FM, Muntion S, Hernandez-Campo P, Santamaria C et al. (2010) Isolation and characterization of mesenchymal stromal cells from human degenerated nucleus pulposus: comparison with bone marrow mesenchymal stromal cells from the same subjects. Spine (Phila Pa 1976) 35, 2259-2265.
109. Lee KI, Moon SH, Kim H, Kwon UH, Kim HJ, Park SN et al. (2012) Tissue engineering of the intervertebral disc with cultured nucleus pulposus cells using atelocollagen scaffold and growth factors. Spine (Phila Pa 1976) 37, 452-458.
110. Liang CZ, Li H, Tao YQ, Peng LH, Gao JQ, Wu JJ et al. (2013) Dual release of dexamethasone and TGF-β3 from polymeric microspheres for stem cell matrix accumulation in a rat disc degeneration model. Acta Biomater. 9, 9423-9433.
111. Blanquer SB, Sharifi S, Grijpma DW (2012) Development of poly(trimethylene carbonate) network implants for annulus fibrosus tissue engineering. J. Appl. Biomater. Funct. Mater. 10, 177-184.